NRP1 is a potential molecule that can modify the tumor microenvironment (TME) and innate immune system in a targeted way to produce an efficient anti-tumor immune response, which binds to and uptakes neutrophil elastin on a number of BRCA cell lines (Kerros et al., 2017). Here, ELN is linked to neoplasm.